Exact Mass: 239.11843199999998
Exact Mass Matches: 239.11843199999998
Found 92 metabolites which its exact mass value is equals to given mass value 239.11843199999998,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Eldoral
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
Emorfazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Methyldopate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
(7aR)-1t-Acetoxy-7-acetoxymethyl-(7ar)-2,3,5,7a-tetrahydro-1H-pyrrolizin|7,9-di-O-acetylretronecine|Diacetat von Retronecin
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide
C12H17NO4_1,3-Dioxolo[4,5-c]pyridin-4(5H)-one, 2-(1-hydroxy-3-methylbutyl)-6-methyl
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide [IIN-based on: CCMSLIB00000848500]
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide [IIN-based: Match]
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide_major
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylpropyl]acetamide_63.7\\%
Methyldopate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD; HY-B0225). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research [1].
N-benzyl-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
3-Amino-3-(4-ethoxy-3-methoxyphenyl)propanoic acid
1-(6,7-dimethoxy-2H-benzo[d]1,3-dioxolan-5-yl)prop-2-ylamine
5-cyclohexylpyridine-2-carboximidamide,hydrochloride
3-(Diethylcarbamoyl)-2-fluorophenylboronic acid
C11H15BFNO3 (239.11289620000002)
1H-Pyrrole-3-propanoic acid, 5- (ethoxycarbonyl)-2,4-dimethyl-
(9-Ethyl-9H-carbazol-3-yl)boronic acid
C14H14BNO2 (239.11175340000003)
N-(2-Aminoethyl)-2-[5-(3-phenoxyphenyl)-2H-tetrazol-2-yl]acetamide
(2S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methyl-propanoic acid
(4-(Butylcarbamoyl)-3-fluorophenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
[3-(Diethylcarbamoyl)-4-fluorophenyl]boronic acid
C11H15BFNO3 (239.11289620000002)
(4-(tert-Butylcarbamoyl)-3-fluorophenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
[3-(Diethylcarbamoyl)-5-fluorophenyl]boronic acid
C11H15BFNO3 (239.11289620000002)
TERT-BUTYL ((4-HYDROXY-6-METHYLPYRIMIDIN-2-YL)METHYL)CARBAMATE
(3-(TERT-BUTYLCARBAMOYL)-4-FLUOROPHENYL)BORONIC ACID
C11H15BFNO3 (239.11289620000002)
(5-(tert-Butylcarbamoyl)-2-fluorophenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
(5-(Diethylcarbamoyl)-2-fluorophenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
(5-(BUTYLCARBAMOYL)-2-FLUOROPHENYL)BORONIC ACID
C11H15BFNO3 (239.11289620000002)
[4-(Diethylcarbamoyl)-3-fluorophenyl]boronic acid
C11H15BFNO3 (239.11289620000002)
(5-fluoro-2-(Morpholinomethyl)phenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
ethyl 2-methylprop-2-enoate,prop-2-enenitrile,prop-2-enoic acid
3-[3-amino-4-(2-methoxyethoxy)phenyl]propanoic acid
1-(2,4-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
N-METHYL-3-(3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-6-YL)ANILINE
2-amino-6-(propan-2-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide
1-[2-AMINO-4-METHOXY-5-(2-METHOXYETHOXY)PHENYL]-ETHANONE
3-AMINO-3-(3-ETHOXY-4-METHOXY-PHENYL)-PROPIONIC ACID
2-(aminomethyl)-3-(3,4-dimethoxyphenyl)propanoic acid
2-diazonio-1-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]ethenolate
3-fluoro-4-(Morpholinomethyl)phenylboronic acid
C11H15BFNO3 (239.11289620000002)
tert-butyl (2R)-2-(2-diazoacetyl)pyrrolidine-1-carboxylate
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,3-THIAZOLE
C11H18BNO2S (239.11512380000002)
(3-(Butylcarbamoyl)-4-fluorophenyl)boronic acid
C11H15BFNO3 (239.11289620000002)
(R)-1-(1H-Benzimidazol-2-yl)-3-methylbutylamine Hydrochloride
6-(2-Formyl-5-hydroxymethyl-pyrrol-1-yl)-caproic acid
Ethyl 2-[(3,5-dimethyl-4-isoxazolyl)methyl]-3-oxobutanoate
3-Methyl-N-(Pyridin-4-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine
Emorfazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1,5-dioxo-octahydroinden-4-yl]propanoate
An oxo monocarboxylic acid anion that is the conjugate base of 5-hydroxy-3-[(3aS,4S,5R,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate, obtained by deprotonation of the carboxy group; major species at pH 7.3.
Acridin Red
C15H15N2O+ (239.11843199999998)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines